Compare Ascendis Pharma A/S (ASND) vs Aterian Inc (ATER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Aterian Inc — how do they compare? Ascendis Pharma A/S trades at $254.01 (market cap $16.67B), while Aterian Inc trades at $0.48 (market cap $5.32M). The key difference: Ascendis Pharma A/S is far larger — about 3133.5× Aterian Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| ASND | ATER | |
|---|---|---|
Market Cap | $16.67B | $5.32M |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $1.39 |
52-Week Low | $189.74 | $0.36 |
Enterprise Value | $17.04B | $5.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →
